BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27000123)

  • 21. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
    Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The challenges of HIV-HCV co-infection].
    Ambrosioni J; Negro F; Calmy A
    Rev Med Suisse; 2012 Apr; 8(338):905-10. PubMed ID: 22611628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
    J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C infection among drug users in northern Thailand.
    Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE
    Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users.
    de Vos AS; van der Helm JJ; Prins M; Kretzschmar ME
    Epidemics; 2012 Jun; 4(2):57-67. PubMed ID: 22664064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France.
    Cacoub P; Dabis F; Costagliola D; Almeida K; Lert F; Piroth L; Semaille C
    Liver Int; 2015 Jan; 35(1):65-70. PubMed ID: 25040895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran.
    Hosseini M; SeyedAlinaghi S; Kheirandish P; Esmaeli Javid G; Shirzad H; Karami N; Jahani M; Seyed Ahmadian M; Payvarmehr F; Mohraz M; Emadi Koochak H; McFarland W
    Arch Iran Med; 2010 Jul; 13(4):318-23. PubMed ID: 20597566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV infection among injecting drug users in Asia: an evolving public health crisis.
    Wodak A; Crofts N; Fisher R
    AIDS Care; 1993; 5(3):313-20. PubMed ID: 8218466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs.
    Ng KT; Takebe Y; Chook JB; Chow WZ; Chan KG; Abed Al-Darraji HA; Kamarulzaman A; Tee KK
    Sci Rep; 2015 Oct; 5():15198. PubMed ID: 26459957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncovering the epidemic of HIV among men who have sex with men in Central Asia.
    Wirtz AL; Kirey A; Peryskina A; Houdart F; Beyrer C
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S17-24. PubMed ID: 23906993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV among female sex workers in the Central Asian Republics, Afghanistan, and Mongolia: contexts and convergence with drug use.
    Baral S; Todd CS; Aumakhan B; Lloyd J; Delegchoimbol A; Sabin K
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S13-6. PubMed ID: 23954072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.
    Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H
    J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and risk factors of hepatitis C virus infection among human immunodeficiency virus (HIV) patients in a large HIV clinic in South Korea.
    Lee S; Lee SH; Lee SJ; Kim KH; Lee JE; Cho H; Lee SG; Chung JS; Kwak IS
    Korean J Intern Med; 2016 Jul; 31(4):772-8. PubMed ID: 27117318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
    Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia].
    Kolovrat A; Jurisić I; Marić Z; Cvitković A
    Acta Med Croatica; 2010 Oct; 64(4):287-96. PubMed ID: 21688612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.